Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo

Clicks: 396
ID: 111417
1997
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Children in the ribavirin treatment group did not have exacerbated respiratory symptoms compared with those in the control group, and their pulmonary function measurements were equal to those of the placebo-treated group, suggesting no long term adverse effect or benefit of ribavirin therapy.
Reference Key
ce1997thelong Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Long CE;Voter KZ;Barker WH;Hall CB;;
Journal the pediatric infectious disease journal
Year 1997
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9384333
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Child Recurrence preschool Clinical Trial Randomized Controlled Trial follow-up studies hospitalization c b hall antiviral agents / therapeutic use* ribavirin / therapeutic use* pmid:9384333 doi:10.1097/00006454-199711000-00004 c e long k z voter growth respiratory syncytial virus infections / drug therapy* respiratory tract infections / drug therapy*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.